Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Bolton, C. Metge, L. Lix, H. Prior, J. Sareen, W. Leslie (2008)
Fracture Risk From Psychotropic Medications: A Population-Based AnalysisJournal of Clinical Psychopharmacology, 28
L. Giangregorio, W. Leslie, L. Lix, H. Johansson, A. Odén, E. McCloskey, J. Kanis (2012)
FRAX underestimates fracture risk in patients with diabetesJournal of Bone and Mineral Research, 27
D. Greenblatt, J. Harmatz, R. Shader (2011)
Psychotropic drug prescribing in the United States: extent, costs, and expenditures.Journal of clinical psychopharmacology, 31 1
D. Black, C. Rosen (2005)
Clinical Practice. Postmenopausal Osteoporosis.The New England journal of medicine, 374 3
Philip Wang, S. Aguilar-Gaxiola, J. Alonso, M. Angermeyer, G. Borges, E. Bromet, R. Bruffaerts, G. Girolamo, R. Graaf, O. Gureje, J. Haro, E. Karam, R. Kessler, V. Kovess, M. Lane, Sing Lee, D. Levinson, Y. Ono, M. Petukhova, J. Posada-Villa, S. Seedat, J. Wells (2007)
Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveysThe Lancet, 370
S. Sattui, K. Saag (2014)
Fracture mortality: associations with epidemiology and osteoporosis treatmentNature Reviews Endocrinology, 10
W. Leslie, L. Lix (2011)
Effects of FRAX(®) model calibration on intervention rates: a simulation study.Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry, 14 3
J. Kanis, N. Harvey, C. Cooper, H. Johansson, A. Odén, E. McCloskey, The Group (2016)
A systematic review of intervention thresholds based on FRAXArchives of Osteoporosis, 11
V. Rabenda, D. Nicolet, C. Beaudart, O. Bruyère, J. Reginster (2012)
Relationship between use of antidepressants and risk of fractures: a meta-analysisOsteoporosis International, 24
S. O'Donnell, Canadian Group (2013)
Use of administrative data for national surveillance of osteoporosis and related fractures in Canada: results from a feasibility studyArchives of Osteoporosis, 8
Qing Wu, A. Bencaz, Joseph Hentz, Michael Crowell (2011)
Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case–control studiesOsteoporosis International, 23
S. Majumdar, J. Ezekowitz, L. Lix, W. Leslie (2012)
Heart failure is a clinically and densitometrically independent risk factor for osteoporotic fractures: population-based cohort study of 45,509 subjects.The Journal of clinical endocrinology and metabolism, 97 4
R. Rizzoli, Chris Cooper, J. Reginster, Bo Abrahamsen, J. Adachi, M. Brandi, O. Bruyère, J. Compston, P. Ducy, Serge Ferrari, N. Harvey, J. Kanis, Gerard Karsenty, A. Laslop, V. Rabenda, P. Vestergaard (2012)
Antidepressant medications and osteoporosis.Bone, 51 3
W. Leslie, L. Lix, H. Johansson, A. Odén, E. McCloskey, J. Kanis (2010)
Independent clinical validation of a Canadian FRAX tool: Fracture prediction and model calibrationJournal of Bone and Mineral Research, 25
D. Redelmeier, S. Tan, G. Booth (1998)
The treatment of unrelated disorders in patients with chronic medical diseases.The New England journal of medicine, 338 21
William Leslie, L. Lix, L. Langsetmo, C. Berger, D. Goltzman, David Hanley, J. Adachi, H. Johansson, A. Odén, E. McCloskey, J. Kanis (2011)
Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatmentOsteoporosis International, 22
D. Altman, Y. Vergouwe, P. Royston, K. Moons (2009)
Prognosis and prognostic research: validating a prognostic modelBMJ : British Medical Journal, 338
Noralou Roos, Charlyn Black, L. Roos, Norman Frohlich, Carolyn DeCoster, Cameron Mustard, Marni Brownell, Marian Shanahan, Patricia Fergusson, F. Toll, Keumhee Carrière, C. Burchill, Randy Fransoo, L. Macwilliam, Bogdan Bogdanovic, David Friesen (1999)
Managing health services: how the Population Health Information System (POPULIS) works for policymakers.Medical care, 37 6 Suppl
J. Kanis, H. Johansson, A. Odén, Chris Cooper, Chris Cooper, E. McCloskey (2014)
Worldwide uptake of FRAXArchives of Osteoporosis, 9
L. Fraser, Kuan Liu, K. Naylor, Y. Hwang, S. Dixon, Salimah Shariff, A. Garg (2015)
Falls and fractures with atypical antipsychotic medication use: a population-based cohort study.JAMA internal medicine, 175 3
A. Kozyrskyj, C. Mustard (1998)
Validation of an Electronic, Population-Based Prescription Database, 32
D. Michelson, C. Stratakis, Lauren Hill, J. Reynolds, E. Galliven, G. Chrousos, P. Gold (1996)
Bone mineral density in women with depression.The New England journal of medicine, 335 16
P. Vestergaard, L. Rejnmark, L. Mosekilde (2006)
Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fractureOsteoporosis International, 17
W. Leslie, P. Caetano, L. Macwilliam, G. Finlayson (2005)
Construction and validation of a population-based bone densitometry database.Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry, 8 1
J. Kanis, E. McCloskey, E. McCloskey, H. Johansson, A. Odén, O. Ström, F. Borgström (2010)
Development and use of FRAX® in osteoporosisOsteoporosis International, 21
A. Schwartz, E. Vittinghoff, D. Bauer, T. Hillier, E. Strotmeyer, K. Ensrud, M. Donaldson, J. Cauley, T. Harris, A. Koster, C. Womack, L. Palermo, D. Black (2011)
Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes.JAMA, 305 21
J. Kanis, O. Johnell, A. Odén, H. Johansson, E. McCloskey (2008)
FRAX™ and the assessment of fracture probability in men and women from the UKOsteoporosis International, 19
J. Woolcott, K. Richardson, M. Wiens, B. Patel, Judith Marin, K. Khan, C. Marra (2009)
Meta-analysis of the impact of 9 medication classes on falls in elderly persons.Archives of internal medicine, 169 21
J. Bolton, L. Targownik, S. Leung, J. Sareen, W. Leslie (2011)
Risk of Low Bone Mineral Density Associated With Psychotropic Medications and Mental Disorders in Postmenopausal WomenJournal of Clinical Psychopharmacology, 31
J. Kanis, Didier Hans, Chris Cooper, Chris Cooper, Sanford Baim, J. Bilezikian, N. Binkley, J. Cauley, J. Compston, B. Dawson-Hughes, G. Fuleihan, H. Johansson, W. Leslie, E. Lewiecki, M. Luckey, A. Odén, S. Papapoulos, C. Poiană, R. Rizzoli, D. Wahl, E. McCloskey (2011)
Interpretation and use of FRAX in clinical practiceOsteoporosis International, 22
E. Hernlund, A. Svedbom, M. Ivergård, J. Compston, Chris Cooper, Chris Cooper, J. Stenmark, E. McCloskey, B. Jönsson, J. Kanis (2013)
Osteoporosis in the European Union: medical management, epidemiology and economic burdenArchives of Osteoporosis, 8
L. Oderda, Jason Young, C. Asche, G. Pepper (2012)
Psychotropic-Related Hip Fractures: Meta-Analysis of First-Generation and Second-Generation Antidepressant and Antipsychotic DrugsAnnals of Pharmacotherapy, 46
M. Tinetti, L. Han, David Lee, G. McAvay, P. Peduzzi, C. Gross, Bingqing Zhou, Haiqun Lin (2014)
Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults.JAMA internal medicine, 174 4
J. Bolton, Wendy Au, W. Leslie, P. Martens, M. Enns, L. Roos, L. Katz, H. Wilcox, A. Erlangsen, D. Chateau, R. Walld, R. Spiwak, M. Séguin, K. Shear, J. Sareen (2013)
Parents bereaved by offspring suicide: a population-based longitudinal case-control study.JAMA psychiatry, 70 2
A. Looker, E. Orwoll, C. Johnston, R. Lindsay, H. Wahner, W. Dunn, M. Calvo, T. Harris, S. Heyse (1997)
Prevalence of Low Femoral Bone Density in Older U.S. Adults from NHANES IIIJournal of Bone and Mineral Research, 12
L. Fraser, L. Langsetmo, C. Berger, G. Ioannidis, D. Goltzman, J. Adachi, A. Papaioannou, R. Josse, C. Kovacs, W. Olszynski, T. Towheed, D. Hanley, S. Kaiser, J. Prior, S. Jamal, N. Kreiger, J. Brown, H. Johansson, A. Odén, E. McCloskey, J. Kanis, W. Leslie, C. Group (2011)
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMosOsteoporosis International, 22
A. Papaioannou, S. Morin, A. Cheung, S. Atkinson, Jacques Brown, Sidney Feldman, D. Hanley, A. Hodsman, S. Jamal, S. Kaiser, B. Kvern, K. Siminoski, W. Leslie (2010)
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summaryCanadian Medical Association Journal, 182
Xing Dan, Xinlong Ma, Jian-xiong Ma, Jie Wang, Y. Yang, Yu-ming Chen (2013)
Association between use of benzodiazepines and risk of fractures: a meta-analysisOsteoporosis International, 25
L. Lix, J. Kuwornu, K. Kroeker, G. Kephart, K. Sikdar, M. Smith, H. Quan (2016)
Estimating the completeness of physician billing claims for diabetes case ascertainment using population-based prescription drug data.Health promotion and chronic disease prevention in Canada : research, policy and practice, 36 3
W. Ray, M. Griffin, W. Schaffner, D. Baugh, L. Melton (1987)
Psychotropic drug use and the risk of hip fracture.The New England journal of medicine, 316 7
ImportanceOsteoporotic fractures are a leading cause of disability, costs, and mortality. FRAX is a tool used to assess fracture risk in the general population. Mental disorders and medications to treat them have been reported to adversely affect bone health, but, to date, they have not been systematically studied in relation to osteoporotic fractures. ObjectiveTo examine the association of mental disorders and psychotropic medication use with osteoporotic fracture risk in routine clinical practice. Design, Setting, and ParticipantsIn this population-based cohort study, bone mineral density and risk factors were used to calculate FRAX scores using data from the Manitoba Bone Density Program database of all women and men 40 years of age or older in Manitoba, Canada, referred for a baseline dual-energy x-ray absorptiometry scan from January 1, 1996, to March 28, 2013. Population-based health services data were used to identify primary mental disorders during the 3 prior years, psychotropic medication use during the prior year, and incident fractures. Cox proportional hazards regression models estimated the risk for incident fractures based on mental disorders and use of psychotropic medications. Data analysis was conducted from November 25, 2013, to October 15, 2016. Main Outcomes and MeasuresIncident nontraumatic major osteoporotic fractures (MOFs) and hip fractures. ResultsOf the 68 730 individuals (62 275 women and 6455 men; mean age, 64.2 [11.2] years) in the study, during 485 322 person-years (median, 6.7 years) of observation, 5750 (8.4%) sustained an incident MOF, 1579 (2.3%) sustained an incident hip fracture, and 8998 (13.1%) died. In analyses adjusted for FRAX score, depression was associated with MOF (adjusted hazard ratio [aHR], 1.39; 95% CI, 1.27-1.51; P < .05) and hip fracture (aHR, 1.43; 95% CI, 1.22-1.69; P < .05) before adjustment for medication use, but these associations were not significant after adjustment for medication use. In contrast, the use of selective serotonin reuptake inhibitors (aHR for MOF, 1.43; 95% CI, 1.27-1.60; P < .05; aHR for hip fracture, 1.48; 95% CI, 1.18-1.85; P < .05), antipsychotics (aHR for MOF, 1.43; 95% CI, 1.15-1.77; P < .05; aHR for hip fracture, 2.14; 95% CI, 1.52-3.02; P < .05), and benzodiazepines (aHR for MOF, 1.15; 95% CI, 1.04-1.26; P < .05; aHR for hip fracture, 1.24; 95% CI, 1.05-1.47; P < .05) were each independently associated with significantly increased risk for both MOF and hip fracture. FRAX significantly underestimated the 10-year risk of MOF by 29% and of hip fracture by 51% for those with depression. It also underestimated the 10-year risk of MOF by 36% for use of selective serotonin reuptake inhibitors, by 63% for use of mood stabilizers, by 60% for use of antipsychotics, and by 13% for use of benzodiazepines. FRAX underestimated the 10-year risk of hip fracture by 57% for use of selective serotonin reuptake inhibitors, by 98% for use of mood stabilizers, by 171% for use of antipsychotics, and by 31% for use of benzodiazepines. FRAX correctly estimated fracture risk in people without mental disorders and those not taking psychotropic medications. Conclusions and RelevanceMental disorders and medication use were associated with an increased risk for fracture, but in simultaneous analyses, only medication use was independently associated with fracture. Depression and psychotropic medication use are potential risk indicators that are independent of FRAX estimates.
JAMA Psychiatry – American Medical Association
Published: Jun 19, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.